US$ 22.79
foxo4-dri dosage calculator FOXO4 peptide targets myofibroblast ameliorates bleomycin‐induced pulmonary fibrosis in mice through ECM‐receptor interaction pathway - Han - 2022 - Journal of Cellular and Molecular Medicine Senolytic Peptide FOXO4-DRI Selectively Removes
Description
This article clearly distinguishes between FDA-approved uses (none) and investigational findings

The most commonly reported events in active arms were mild and transient: injection site reactions in some subcutaneous subjects, occasional headache, and in some oral dosing arms, minor gastrointestinal tolerance issues

References Neelakantan H, et al

This study therefore demonstrates superiority of local administration of these agents over IM administration for AOHN

u 19:00h 29

If youre not deficient, routine injections are seldom necessary
